Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice. - Test2 - elhamkhani - TriplyDB

Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.

Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.

http://www.wikidata.org/entity/Q36526062

about

The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function NAFLD and Chronic Kidney Disease Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiency ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation Translation of Angiotensin-Converting Enzyme 2 upon Liver- and Lung-Targeted Delivery of Optimized Chemically Modified mRNA Gene profile of chemokines on hepatic stellate cells of schistosome-infected mice and antifibrotic roles of CXCL9/10 on liver non-parenchymal cells Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver Obesity, diabetes mellitus, and liver fibrosis.Angiotensin converting enzyme 2: a new important player in the regulation of glycemia.Gardenia jasminoides attenuates hepatocellular injury and fibrosis in bile duct-ligated rats and human hepatic stellate cells Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis ACE2 Therapy Using Adeno-associated Viral Vector Inhibits Liver Fibrosis in Mice CD36/Sirtuin 1 Axis Impairment Contributes to Hepatic Steatosis in ACE2-Deficient Mice.Hepatocyte specific expression of an oncogenic variant of β-catenin results in cholestatic liver disease The role of the renin-angiotensin system in liver fibrosis.Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.Angiotensin-(1-7): beyond the cardio-renal actions.Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention.The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.Renin angiotensin system in liver diseases: Friend or foe?Effects of Yinchenhao decoction on self-regulation of renin-angiotensin system by targeting angiotensin converting enzyme 2 in bile duct-ligated rat liver.Therapeutic effect of renin angiotensin system inhibitors on liver fibrosis.Recombinant Expression and Characterization of Human and Murine ACE2: Species-Specific Activation of the Alternative Renin-Angiotensin-System.Angiotensin-converting enzyme 2 autoantibodies: further evidence for a role of the renin-angiotensin system in inflammation.Intrarenal Angiotensin-Converting Enzyme: the Old and the New.Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects.High-fat diet-induced glucose dysregulation is independent of changes in islet ACE2 in mice.Mesenchymal Stem Cells Overexpressing Angiotensin-Converting Enzyme 2 Rescue Lipopolysaccharide-Induced Lung Injury.The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).Loss of angiotensin converting enzyme II (ACE2) accelerates the development of liver injury induced by thioacetamide.Swertiamarin Attenuates Experimental Rat Hepatic Fibrosis by Suppressing Angiotensin II-Angiotensin Type 1 Receptor-Extracellular Signal-Regulated Kinase Signaling.Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension.

P2860

Q24633556-BB31C30A-C7DE-4363-8E4D-AB9C822E2C98 Q26752759-89A362C3-2E3D-4752-A2AE-98DFDB03F3C8 Q27324830-CBF3DF18-BE47-4556-AA2F-43233E1CAC0A Q28585962-F5AF4E4E-B6EF-4CB1-8B30-37561CB453E6 Q33652543-C7E62F04-AAD6-4B6B-A6B1-4CC55872C801 Q34384443-7EBD25A4-865E-44F3-B207-8E75A1AD01E6 Q34471885-0FD1652C-E870-4F59-9945-2EB52B68F38C Q34979922-54788B0E-A939-413B-820D-466A6F47749E Q36020040-E12A5CC5-D2B5-4E9E-B34F-6ABACC67D44D Q36529136-AB478273-B434-4977-A4DD-88DFB1D17096 Q36587510-B32ADAAF-2CFA-4800-B0B5-BD00C52E2325 Q36757066-90E41059-29E9-4F96-840F-502509AAA02B Q37560592-220140E4-AF6A-427F-A494-1B4239BACEB4 Q37699357-BA0394C6-0C7C-4EC8-8897-E520A650332F Q37867350-BC039C3B-0B76-46AB-B355-4E0D37BFECA5 Q38006726-3DDA606B-D1FF-47F1-9219-3B3DA54ADFD8 Q38068237-C6C95692-2183-4149-B9B8-EB52CAC10D2B Q38879747-60276E02-7389-4CFB-BE3D-266D6E0A5967 Q38945443-F8DA2F23-C376-4DA3-A031-7A4E4CEB4033 Q39360840-192A09EB-48B0-454E-B15F-A77290220638 Q40680622-13944674-45E1-41B6-BE9F-3CE8EBC87C51 Q40743246-24A2BE94-F1B6-43B4-9CE5-BD98B1931FD7 Q42589155-BA94B22B-4F7B-4FB0-8CF7-88EF43D07AE6 Q42663141-62B04D56-35D7-4AA4-90F6-9551B548423E Q45067801-C46B5471-E2C1-4E07-91DE-10102D58215E Q45276776-48498AC4-20D5-410B-A89E-A331861603AF Q45848259-01065E6A-EE55-4787-AAD8-74D4F908A986 Q45869181-B043484C-6373-4962-8F36-8A9FB549C6EE Q47851502-9ABCA4F4-38AE-4DB2-A603-E1787E5DAB93 Q50223405-9398571C-3543-47C8-AFBF-7214622CC93C Q50230517-BE250E08-E631-42D5-8FAD-68F75012E8D1 Q55363090-3C7C9337-8770-4644-B85E-F8A11F269E7E

P2860

Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.

http://www.wikidata.org/entity/Q36526062

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.

@ast

Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.

@en

type

label

Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.

@ast

Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.

@en

prefLabel

Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.

@ast

Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.

@en

P1433

Q36526062-DEFDF52D-1547-4C55-9E74-A502D44F15EE

P1476

Q36526062-29C79D45-BFE4-4F65-95B1-B5BC47C406E9

P2093

Q36526062-023308AF-8B7E-40BB-8EB5-30142B75D47E

Q36526062-349B334E-E039-49F8-AFAE-931723C4892D

Q36526062-70590FCA-09DE-4E84-96FA-C5E756ED3981

Q36526062-78C35910-746E-4278-B3AB-3DEA5F1C6178

Q36526062-B36CB40D-FEA0-47CB-83A7-2F576FB02C80

Q36526062-BCE17B83-871F-4EA7-AD02-E727AAA6B2F2

Q36526062-DF7C10E9-8D06-4441-9275-18B01DAB9246

Q36526062-F207D172-FA00-4520-A108-85B2FDA4000A

Q36526062-F5F26EA6-0A3A-4DBB-B4F4-9D100A9D79BF

P2860

Q36526062-0008166D-AB3E-4321-9802-85091EFBED80

Q36526062-0A3C9AD3-201F-4135-B9F5-472A5B936CE3

Q36526062-0FD6284C-AB11-492A-9ABD-570DF53A2971

Q36526062-17F7CBB6-78E8-44A0-ACC7-7D47CF8E0E9C

Q36526062-1F7FE9A3-FC1A-4D32-9E4A-36B0FB0E4B13

Q36526062-20A702A6-E563-4A09-9847-F7B059EA3638

Q36526062-31283D99-FBEA-47AD-9E46-7ACE99EE0F44

Q36526062-39D1199A-7819-4A8C-A93C-7C0EC8EABA70

Q36526062-41F7AC25-B941-445B-B494-C8C0458AC4FA

Q36526062-43A3A960-2C26-4C60-89F4-4F247C9A0234

P304

Q36526062-ACAF058A-8503-4AB6-BB90-2A10B00B55FC

P31

Q36526062-2C6B61A6-4B23-4C62-B32E-2A85BED9DECB

P356

Q36526062-2DBF1F97-C3F7-436B-8FF0-D1A0ABCD8B8D

P407

Q36526062-393F2FC3-2E37-4FB6-9687-4DD77AE77D11

P433

Q36526062-D88896E8-08F7-425F-9405-F7D18A39AF99

P478

Q36526062-C64194DE-BDCB-44B8-B65C-E71440375FAC

P50

Q36526062-8D48EF19-9046-4794-BDF4-4C8161E69C57

Q36526062-D6CA1D7F-6611-4E49-9E75-7639BDD04B71

P577

Q36526062-4FB158A4-7132-4B69-B6D8-4969D0F5716A

P5875

Q36526062-146B883D-CF05-4A6B-BCFC-C62B943DC82B

P698

Q36526062-58D6E770-2E02-4DFC-B757-36619D82F631

P932

Q36526062-E05EEDC2-93A4-4850-9D05-9D2EC6527A92

P356

P1433

P1476

Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.

@en

P2093

Christoph H Osterreicher

http://www.w3.org/2001/XMLSchema#string

Ekihiro Seki

http://www.w3.org/2001/XMLSchema#string

Gavin Y Oudit

http://www.w3.org/2001/XMLSchema#string

Johannes Kluwe

http://www.w3.org/2001/XMLSchema#string

Kojiro Taura

http://www.w3.org/2001/XMLSchema#string

Manfred Schuster

http://www.w3.org/2001/XMLSchema#string

Melitta Penz-Osterreicher

http://www.w3.org/2001/XMLSchema#string

Samuele De Minicis

http://www.w3.org/2001/XMLSchema#string

Yuzo Kodama

http://www.w3.org/2001/XMLSchema#string

P2860

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

Angiotensin-converting enzyme 2 is an essential regulator of heart function

The hepatic apelin system: a new therapeutic target for liver disease

Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor

TLR4 enhances TGF-beta signaling and hepatic fibrosis

Neurotensin is a proinflammatory neuropeptide in colonic inflammation

Just the beginning: novel functions for angiotensin-converting enzymes.

Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis

Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2.

P304

929-938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.23104

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Josef M Penninger

David A. Brenner

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26712510

http://www.w3.org/2001/XMLSchema#string

P698

19650157

http://www.w3.org/2001/XMLSchema#string

P932

4734904

http://www.w3.org/2001/XMLSchema#string